miR Scientific

miR Scientific is a precision bioscience company that provides non-invasive liquid biopsy urine testing technology to accurately detect and precisely classify prostate cancer and bladder cancer at the molecular level with industry-leading sensitivity and specificity. miR Scientific's molecular diagnostic capabilities are achieved through a novel lens incorporating advanced sncRNA interrogation technology, proprietary scoring algorithms, and innovative clinical decision support tools for cancer detection, classification, and monitoring. miR’s product portfolio includes the Prostate Cancer Sentinel Test (tm), a urine-based liquid biopsy test with unprecedented accuracy that could save thousands of men from the severe side effects of unnecessary prostate cancer treatments. The company was spun off in commercial form from the Cancer Research Center in Albany, New York State, in 2014 and currently operates in Rochester, New York City, Israel, and Canada.